Award

20ZR1433700

Funder: National Natural Science Foundation of China

Funded outputs count: 6

Funder award ID: 20ZR1433700

OpenAlex ID: G7621633461

Machine learning models in evaluating the malignancy risk of ovarian tumors: a comparative study

2024 · Xin He, Xiang-Hui Bai, et al. · Journal of Ovarian Research · 15

Can surgery boost the survival benefit of chemoradiotherapy in T1b1-T2a1 stage cervical cancer with lymph node metastasis? A population-based study

2024 · Yiwei Wang, You Lyu, et al. · Journal of Gynecologic Oncology · 4

Targeting Adhesive Tumor Adventitia via Injectable Electrospun Short Fibers in Perfusion of Intraperitoneal Sporadic Tumors

2023 · Dan Ruan, Juan Wang, et al. · Small Methods · 9

Mutational profiles of ovarian cancer in Chinese patients reveal potential therapeutic targets and prognostic markers

2022 · Tianjiao Lyu, Yahui Jiang, et al. · Research Square

Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis

2022 · Jingjing Zhang, Yun Li, et al. · Journal of Experimental & Clinical Cancer Research · 67

Identification and Functional Validation of Differentially Expressed microRNAs in Ascites-Derived Ovarian Cancer Cells Compared with Primary Tumour Tissue

2021 · Yahui Jiang, Yiwen Shi, et al. · Cancer Management and Research · 12